Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.95 and has seen 79296.0 shares traded in the last trading session. The company, currently valued at $2.49M, closed the last trade at $0.63 per share which meant it gained $0.03 on the day or 5.05% during that session. The QNRX stock price is -973.02% off its 52-week high price of $6.76 and 23.81% above the 52-week low of $0.48. If we look at the company’s 10-day average daily trading volume, we find that it stood at 63310.0 shares traded. The 3-month trading volume is 47.76K shares.
The consensus among analysts is that Quoin Pharmaceuticals Ltd ADR (QNRX) is Buy stock at the moment, with a recommendation rating of 1.67. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Sporting 5.05% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNRX stock price touched $0.63 or saw a rise of 3.08%. Year-to-date, Quoin Pharmaceuticals Ltd ADR shares have moved -87.24%, while the 5-day performance has seen it change 3.54%. Over the past 30 days, the shares of Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) have changed 8.70%. Short interest in the company has seen 2623.0 shares shorted with days to cover at 0.06.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Figures show that Quoin Pharmaceuticals Ltd ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -77.40% over the past 6 months, with this year growth rate of 67.53%, compared to 20.20% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 67.35% over the past 5 years.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
